Patient Lifestyle

But when Marcia's condition deteriorated and she needed palliative care about a year ago, Marcaccio reached out for help from Ontario's home care system.

The regulatory filings include clinical data from a trial of 30,000 participants in the U.S. and Mexico, which found 100% protection against moderate and severe disease and 90.4% efficacy overall, Novavax said.

The Nikean Psychedelic Psychotherapy Research Centre at University Health Network in Toronto expects to launch its first course at the start of 2022.

Non-immunogenic cancers have best outcomes—according to findings at the Anesthesiology 2021 annual meeting of a large retrospective study comparing 90-day survival.